We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BBP market cap is 16.47M. The company's latest EPS is USD 1.0567 and P/E is 51.43.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 85k | 92k | 61k | 33k | 28k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 271k | 6.54M | 2.03M | -2.33M | 317k |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.24M | 28.17M | 25.08M | 16.61M | 14.01M |
| Total Liabilities | 1.74M | 1.67M | 1.75M | 258k | 10k |
| Total Equity | 26.51M | 26.51M | 23.33M | 16.35M | 14M |
| Market Cap | 16.47M |
| Price to Earnings Ratio | 51.43 |
| Price to Sales Ratio | 582.53 |
| Price to Cash Ratio | 135.88 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 300k |
| Average Volume (1 week) | 595 |
| Average Volume (1 Month) | 1.09k |
| 52 Week Change | 6.25% |
| 52 Week High | 63.25 |
| 52 Week Low | 45.00 |
| Spread (Intraday) | 4 (7.05%) |
| Company Name | Virtus LifeSci Biotech Products ETF |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
